Skip to main content
SpringerLink
Log in

Circulating MicroRNA as Novel Potential Biomarkers for the Diagnosis of Highly Malignant Gliomas

  • Published:
Neuroscience and Behavioral Physiology Aims and scope Submit manuscript

Highly malignant glial tumors (highly malignant gliomas) are the most aggressive primary brain neoplasms. Understanding of the pathogenesis and development of new and effective diagnostic and therapeutic methods is therefore of great interest. MicroRNAs are short noncoding RNA molecule of length 18–22 nucleotides which have been shown to play a direct role in carcinogenesis. Circulating microRNA are released into the extracellular space and can remain stable for long periods of time in most biological fluids, including serum and plasma. Circulating microRNA are potential biomarkers for different expression profiles specific for different human diseases, including oncological diseases. Many data have been obtained showing that different circulating microRNA profiles in human biological fluids particularly in extracellular vesicles, are linked with numerous neoplastic processes, such that microRNA may constitute a new class of biomarkers for early diagnosis and prognosis of highly malignant gliomas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. J. A. Schwartzbaum, J. L. Fisher, K. D. Aldape, and M. Wrensch, “Epidemiology and molecular pathology of glioma,” Nat. Clin. Pract. Neurol., 2, 494–503 (2006), https://doi.org/10.1038/ncpneuro0289.

    Article  Google Scholar 

  2. N. Mutter and R. Stupp, “Temozolomide: a milestone in neurooncology and beyond?” Expert Rev. Anticancer Ther., 6, 1187–204 (2006), https://doi.org/10.1586/14737140.6.8.1187.

    Article  CAS  Google Scholar 

  3. R. Stupp, M. E. Hegi, W. P. Mason, et al., “Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomized phase III study: 5-Year analysis of the EORTC-NCIC trial,” Lancet Oncol, 10, 459–466 (2009), https://doi.org/10.1016/S1470-2045(09)70025-7.

    Article  CAS  Google Scholar 

  4. D. MicroRNA as potential, L. Stalpers, W. Taal, et al., “Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas,” Lancet Oncol, 9, 453–461 (2008), https://doi.org/10.1016/S1470-2045(08)70125-6.

  5. S. A. MacLellan, C. MacAulay, S. Lam, and C. Garnis, “Pre-profi ling factors influencing serum microRNA levels,” BMC Clin. Pathol., 14, 27–38 (2014), https://doi.org/10.1186/1472-6890-14-27.

    Article  Google Scholar 

  6. P. Roth, J. Wischhusen, C. Happold, et al., “A specifi c miRNA signature in the peripheral blood of glioblastoma patients,” J. Neurochem., 118, 449–457 (2011), https://doi.org/10.1111/j.1471-4159.2011.07307.x.

    Article  CAS  Google Scholar 

  7. D. N. Louis, A. Perry, G. Reifenberger, et al., “The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary,” Acta Neuropathol., 131, 803–820 (2016),https://doi.org/10.1007/s00401-016-1545-1.

    Article  Google Scholar 

  8. Z. Areeb, S. S. Stylli, R. Koldej, et al., “MicroRNA as potential biomarkers in glioblastoma,” J. Neurooncol., 125, 237–248 (2015), https://doi.org/10.18632/oncotarget.14445.

    Article  CAS  PubMed  Google Scholar 

  9. X. Ye, W. Wei, Z. Zhang, et al., “Identifi cation of microRNAs associated with glioma diagnosis and prognosis,” Oncotarget, 8, 26394–26403 (2017), https://doi.org/10.18632/oncotarget.14445.

    PubMed  PubMed Central  Google Scholar 

  10. M. Westphal and K. Lamszus, “Circulating biomarkers for gliomas,” Nat. Rev. Neurol., 11, 556–566 (2015), https://doi.org/10.1038/nrneurol.2015.171.

  11. Y. He, J. Lin, D. Kong, et al., “Current state of circulating microRNAs as cancer biomarkers,” Clin. Chem., 61, 1138–1155 (2015), https://doi.org/10.1373/clinchem.2015.241190.

    Article  CAS  Google Scholar 

  12. J. R. Chevillet, J. Lee, H. A. Briggs, et al., “Issues and prospects of microRNA-based biomarkers in blood and other body fl uids,” Molecules, 19, 6080–6105 (2014), https://doi.org/10.3390/molecules19056080.

    Article  Google Scholar 

  13. N. Kosaka, Y. Yoshioka, Y. Fujita, and T. Ochiya, “Versatile roles of extracellular vesicles in cancer,” J. Clin. Invest., 126, 1163–1172 (2016), https://doi.org/10.1172/JCI81130.

    Article  Google Scholar 

  14. R. Kalluri, “The biology and function of exosomes in cancer,” J. Clin. Invest., 126, 1208–1215 (2016), https://doi.org/10.1172/JCI81135.

    Article  Google Scholar 

  15. J. Skog, T. Wurdinger, S. van Rijn, et al., “Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers,” Nat. Cell Biol., 10, 1470–1476 (2008), https://doi.org/10.1038/ncb1800.

    Article  CAS  Google Scholar 

  16. C. Villarroya-Beltri, C. Gutierrez-Vazquez, F. Sanchez-Cabo, et al., “Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specifi c motifs,” Nat. Commun., 4, 2980–2990 (2013), https://doi.org/10.1038/ncomms3980.

    Article  Google Scholar 

  17. G. Regazzo, I. Terrenato, M. Spagnuolo, et al., “A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas,” J. Exp. Clin. Cancer Res., 35, 124–135 (2016), https://doi.org/10.1186/s13046-016-0393-0.

  18. J. M. Figueroa and B. S. Carter, “Detection of glioblastoma in biofluids,” J. Neurosurg., 129, No. 2, 334–340 (2018), https://doi.org/ https://doi.org/10.3171/2017.3.JNS162280.19.

    Article  CAS  PubMed  Google Scholar 

  19. T. Siegal, H. Charbit, I. Paldor, et al., “Dynamics of circulating hypoxia-mediated miRNAs and tumor response in patients with highgrade glioma treated with bevacizumab,” J. Neurosurg., 125, 1008–1015 (2016), https://doi.org/10.3171/2015.8.JNS15437.

    Article  CAS  Google Scholar 

  20. C. A. Tumilson, R. W. Lea, J. E. Alder, and L. Shaw, “Circulating MicroRNA biomarkers for glioma and predicting response to therapy,” Mol. Neurobiol., 50, 545–558 (2014), https://doi.org/10.1007/s12035-014-8679-8.

  21. S. Jia, D. Zocco, M. L. Samuels, et al., “Emerging technologies in extracellular vesicle-based molecular diagnostics,” Expert Rev. Mol. Diagn., 14, 307–321 (2014), https://doi.org/10.1586/14737159.2014. 893828.

    Article  CAS  Google Scholar 

  22. S. M. Evans, M. Putt, X. Y. Yang, et al., “Initial evidence that bloodborne microvesicles are biomarkers for recurrence and survival in newly diagnosed glioblastoma patients,” J. Neurooncol., 127, 391–400 (2016), https://doi.org/10.1007/s11060-015-2051-3.

    Article  CAS  Google Scholar 

  23. Y. H. Feng and C. J. Tsao, “Emerging role of microRNA-21 in cancer (Review),” Biomed. Rep., 5, 395–402 (2016), https://doi.org/10. 3892/br.2016.747.

  24. L. Manterola, E. Guruceaga, J. G. Perez-Larraya, et al., “A small noncoding RNA signature found in exosomes of GBM patient serum as a diagnostic tool,” Neuro Oncol., 16, 520–527 (2014), PMID: 24435880, https://doi.org/10.1093/neuonc/not218.

    Article  CAS  Google Scholar 

  25. A. Turchinovich, L. Weiz, A. Langheinz, and B. Burwinkel, “Characterization of extracellular circulating microRNA,” Nucleic Acids Res., 39, 7223–7233 (2011), https://doi.org/10.1093/nar/gkr254.

    Article  CAS  Google Scholar 

  26. Q. Wang, P. Li, A. Li, et al., “Plasma specifi c miRNAs as predictive biomarkers for diagnosis and prognosis of glioma,” J. Exp. Clin. Cancer Res., 31, 97–107 (2012), https://doi.org/10.1186/1756-9966-31-97.

    Article  CAS  Google Scholar 

  27. P. Ivo D’Urso, O. F. Urso, and C. D. Gianfreda, “MiR-15b and miR-21 as circulating biomarkers for diagnosis of glioma,” Curr. Genomics, 16, 304–311 (2015), https://doi.org/10.2174/138920291 6666150707155610.

    Article  Google Scholar 

  28. R. Zhang, B. Pang, T. Xin, et al., “Plasma miR-221/222 family as novel descriptive and prognostic biomarkers for glioma,” Mol. Neurobiol., 53, 1452–1460 (2016).

    Article  CAS  Google Scholar 

  29. F. Zhi, N. Shao, R. Wang, et al., “Identifi cation of 9 serum microRNAs as potential noninvasive biomarkers of human astrocytoma,” Neuro Oncol., 17, 383–391 (2015), https://doi.org/10.1093/neuonc/nou169.

    Article  CAS  Google Scholar 

  30. N. S. Lai, D. Wu, X. Fang, et al., “Serum microRNA-210 as a potential noninvasive biomarker for the diagnosis and prognosis of glioma,” Br. J. Cancer, 112, 1241–1246 (2015), https://doi.org/10.1038/bjc.2015.91.

    Article  CAS  Google Scholar 

  31. J. Wu, L. Li, and C. Jiang, “Identification and evaluation of serum microRNA-29 family for glioma screening,” Mol. Neurobiol., 52,1540–1546 (2015), https://doi.org/10.1007/s12035-014-8937-9.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Bashkir State Medical University, Ministry of Health of the Russian Federation, Ufa, Russia

    I. F. Gareev, L. B. Novicova & O. A. Beylerli

Authors
  1. I. F. Gareev
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. B. Novicova
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. O. A. Beylerli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to I. F. Gareev.

Additional information

Translated from Zhurnal Nevrologii i Psikhiatrii imeni S. S. Korsakova, Vol. 119, No. 5, Iss. 1, pp. 86–90, May, 2019.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gareev, I.F., Novicova, L.B. & Beylerli, O.A. Circulating MicroRNA as Novel Potential Biomarkers for the Diagnosis of Highly Malignant Gliomas. Neurosci Behav Physi 50, 283–287 (2020). https://doi.org/10.1007/s11055-020-00899-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11055-020-00899-x

Keywords

Search

Navigation